FDA clears Abbott's blood test for concussion
Abbott (NYSE:ABT) received FDA clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test.
Source: massdevice.com
Stay updated with breaking news from Alinityi Abbott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott (NYSE:ABT) received FDA clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test.